UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 504

Sortiert nach

A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

The American journal of surgical pathology, 2016-09, Vol.40 (9), p.1192-1202

2016

Link zum Volltext

Verfügbarkeit prüfen

The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

The American journal of surgical pathology, 2015-05, Vol.39 (5), p.683-690

2015

Link zum Volltext

Verfügbarkeit prüfen

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

Science (American Association for the Advancement of Science), 2011-03, Vol.331 (6021), p.1199-1203

2011

Link zum Volltext

Verfügbarkeit prüfen

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Nature communications, 2018-10, Vol.9 (1), p.4158-10, Article 4158

2018

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype

The American journal of surgical pathology, 2019-06, Vol.43 (6), p.851

2019

Link zum Volltext

Verfügbarkeit prüfen

Validation of a digital pathology system including remote review during the COVID-19 pandemic

Modern pathology, 2020-11, Vol.33 (11), p.2115-2127

2020

Link zum Volltext

Verfügbarkeit prüfen

The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater

The American journal of surgical pathology, 2014-10, Vol.38 (10), p.1371-1379

2014

Link zum Volltext

Verfügbarkeit prüfen

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

The American journal of surgical pathology, 2012-02, Vol.36 (2), p.173-184

2012

Link zum Volltext

Verfügbarkeit prüfen

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study

Annals of surgical oncology, 2016-04, Vol.23 (4), p.1361-1370

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver

The American journal of surgical pathology, 2017-07, Vol.41 (7), p.915-922

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades

Annals of surgical oncology, 2012-01, Vol.19 (1), p.169-175

2012

Link zum Volltext

Verfügbarkeit prüfen

Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

Molecular cell, 2010-06, Vol.38 (5), p.689-699

2010

Link zum Volltext

Verfügbarkeit prüfen

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

Annals of surgical oncology, 2015-10, Vol.22 (11), p.3512-3521

2015

Link zum Volltext

Verfügbarkeit prüfen

Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate

The American journal of surgical pathology, 2013-11, Vol.37 (11), p.1671-1677

2013

Link zum Volltext

Verfügbarkeit prüfen

Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma

Annals of surgical oncology, 2014-05, Vol.21 (5), p.1678-1685

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers

PloS one, 2012-07, Vol.7 (7), p.e40157-e40157

2012

Link zum Volltext

Verfügbarkeit prüfen

Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

Annals of surgery, 2022-12, Vol.276 (6), p.1017

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence

Annals of surgical oncology, 2021-09, Vol.28 (9), p.4829-4838

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set

The American journal of surgical pathology, 2010-03, Vol.34 (3), p.300-313

2010

Link zum Volltext

Verfügbarkeit prüfen

Bcl-xL promotes metastasis independent of its anti-apoptotic activity

Nature communications, 2016-01, Vol.7 (1), p.10384-10384, Article 10384

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma

JAMA surgery, 2019-02, Vol.154 (2), p.126

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis

Human pathology, 2010-05, Vol.41 (5), p.643-652

2010

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Classification and Clinical Behavior of the Spectrum of Goblet Cell Carcinoid Tumors of the Appendix

The American journal of surgical pathology, 2008-10, Vol.32 (10), p.1429-1443

2008

Link zum Volltext

Verfügbarkeit prüfen

BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma

Journal of clinical oncology, 2009-01, Vol.27 (3), p.433-438

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 504

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(474)
Mit Volltextzugriff
(447)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype

Validation of a digital pathology system including remote review during the COVID-19 pandemic

The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study

Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma

Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades

Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate

Stage-Stratified Prognosis of Signet Ring Cell Histology in Patients Undergoing Curative Resection for Gastric Adenocarcinoma

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers

Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence

Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set

Bcl-xL promotes metastasis independent of its anti-apoptotic activity

Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma

Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis

Pathologic Classification and Clinical Behavior of the Spectrum of Goblet Cell Carcinoid Tumors of the Appendix

BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma

Suchergebnisse filtern